直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
Adriana L. Burgy
Partner
More
vCard
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
+1 202 408 4345
adriana.burgy@finnegan.com adriana.burgy@finnegan.com

Adriana L. Burgy

Partner

  • +1 202 408 4345 +1 202 408 4345
  • adriana.burgy@finnegan.com adriana.burgy@finnegan.com
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
  • vCard

Adriana Burgy’s practice focuses on opinion work, client counseling, patent prosecution and management, and litigation in the chemical, pharmaceutical, and biotechnology arts. Adriana brings a unique perspective by blending her legal, technical, and industry experience.

Recognized for her practice in the Washington, DC region by Intellectual Asset Management (IAM) and by The Legal 500 U.S. for patent prosecution, re-examinations, and post-grant proceedings, Adriana counsels her clients on a diverse range of patent issues. She has managed the prosecution of hundreds of patent applications domestically and internationally directed to consumer products, pharmaceuticals, and small molecules. She assists clients on single-patent issues as well as complex matters involving multiple patents and applications requiring ongoing advice on patent portfolio strategy and development, with an eye towards litigation. Client counseling also comprises Adriana’s practice. She has assisted clients in the early stages of development through due diligence and patent portfolio analysis. Additionally, Adriana frequently counsels clients regarding prelitigation considerations. 

From a patent prosecution perspective, Adriana has drafted and prosecuted numerous patent applications domestically and internationally, guided and advised clients on complex procedural and legal issues surrounding clients patent portfolios, developed and implemented strategic prosecution in support of ongoing litigation, generated strategies for maximizing investment in patent portfolios, and facilitated the identification of high-priority applications within patent portfolios. Adriana’s experience includes patentability searching, reexaminations and reissues, and appeals to the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO). With the changing landscape under the America Invents Act (AIA), Adriana has counseled clients to prepare for the historic reforms, and to develop long-term strategies moving forward under this new regime. Adriana previously served as leader of Finnegan’s patent office practice.

Adriana routinely provides legal education and client seminars on various aspects of U.S. patent law and practice with a particular emphasis on practical tips and applications. She has presented on a range of topics, including patent application drafting, patent infringement, validity, and enforceability; restriction requirement practice; obviousness and the use of effective post-filing evidence; and various AIA topics. 

Et Cetera

  • Coauthor. "Acquiring and In-Licensing Pharmaceutical Products: Due Diligence Issues," Pre-ANDA Litigation: Strategies and Tactics for Developing a Drug Product and Patent Portfolio, Second Edition, 2018.
  • Editor-in-chief of IDEA: The Journal of Law and Technology, 2001-2002.
  • Served as legal extern to the Honorable James E. Duggan, Justice at the New Hampshire Supreme Court, 2001.
  • Served as teaching assistant for Franklin Pierce Law Center's Fundamentals of Intellectual Property course, 2001.
  • Analytical chemist at MedImmune, Inc. and Genetic Therapy, Inc., 1996-1999.

Experience

Boston Heart Diagnostics Corp. v. Health Diagnostic Laboratory, Inc.

Successfully represented HDL in an inter partes review (IPR) brought by Boston Heart related to HDL's patent directed to screening methods for pre-diabetes, resulting in PTAB denying instituting the petition.

IPR2015-00557, PTAB, Judges Elluru, Franklin, Paulraj

Insights

Conference

2026 Advanced Chemical & Biotech Patent Institute 2026 Advanced Chemical & Biotech Patent Institute

May 11-12, 2026

San Francisco

Webinar

Inherency Doctrine in Patent Prosecution and Litigation 2025 Inherency Doctrine in Patent Prosecution and Litigation 2025

December 18, 2025

Webinar

Prosecution First Blog

USPTO Introduces AI-Assisted Prior Art Search: Key Details for Applicants USPTO Introduces AI-Assisted Prior Art Search: Key Details for Applicants

November 4, 2025

Prosecution First Blog

USPTO’s Streamlined Claim Set Pilot Program: Accelerating Patent Approvals USPTO’s Streamlined Claim Set Pilot Program: Accelerating Patent Approvals

November 4, 2025

Articles

Intellectual Property Rights in the United States: Overview

Intellectual Property Rights in the United States: Overview Intellectual Property Rights in the United States: Overview

November 1, 2025

Thomson Reuters

Webinar

Patenting Pharmaceutical Drug Formulations: Withstanding Litigation and PTAB Challenges Patenting Pharmaceutical Drug Formulations: Withstanding Litigation and PTAB Challenges

January 9, 2025

Webinar

More

Professional Recognition

"Burgy is at her best when working in the chemical, pharmaceutical and biotechnology fields."

Intellectual Property Management Patent 1000

“A sought-after opinion giver, Burgy demonstrates a mastery of both complex chemical and life sciences technology and patent strategy.”

Intellectual Asset Management Patent 1000

“…Chemical and biotech specialist Adriana Burgy…‘provides exceptional thinking in terms of navigating patent prosecution in light of competing technology…’”

Legal 500 United States

“Keeping the patent office practice in the best of health in her role as its captain is Adriana Burgy.”

Intellectual Asset Management Patent 1000

“‘She stays consistently on top of complex portfolios and makes herself available at all times. Her team engages fully in scientific discussions with inventors to master the subject matter and is head and shoulders above others in terms of providing an efficient, highly specialized prosecution service.’”

Intellectual Asset Management Patent 1000

“Burgy captains the patent office practice and leads the way on the patenting of cutting-edge life sciences technologies, leveraging litigation experience to maximise long-term protections…”

Intellectual Property Management Patent 1000

"Burgy is at her best when working in the chemical, pharmaceutical and biotechnology fields."

Intellectual Property Management Patent 1000

“A sought-after opinion giver, Burgy demonstrates a mastery of both complex chemical and life sciences technology and patent strategy.”

Intellectual Asset Management Patent 1000

“…Chemical and biotech specialist Adriana Burgy…‘provides exceptional thinking in terms of navigating patent prosecution in light of competing technology…’”

Legal 500 United States

“Keeping the patent office practice in the best of health in her role as its captain is Adriana Burgy.”

Intellectual Asset Management Patent 1000

“‘She stays consistently on top of complex portfolios and makes herself available at all times. Her team engages fully in scientific discussions with inventors to master the subject matter and is head and shoulders above others in terms of providing an efficient, highly specialized prosecution service.’”

Intellectual Asset Management Patent 1000

“Burgy captains the patent office practice and leads the way on the patenting of cutting-edge life sciences technologies, leveraging litigation experience to maximise long-term protections…”

Intellectual Property Management Patent 1000

News

Award/Ranking

Finnegan Partner Adriana Burgy Named a 2025 BTI Client Service All-Star

Finnegan Partner Adriana Burgy Named a 2025 BTI Client Service All-Star

August 21, 2025

BTI Consulting Group

Award/Ranking

50 Finnegan Attorneys Ranked in the 2025 IAM Patent 1000

50 Finnegan Attorneys Ranked in the 2025 IAM Patent 1000

June 2, 2025

Intellectual Asset Management (IAM)

Award/Ranking

46 Finnegan Attorneys Ranked in 2024 IAM Patent 1000

46 Finnegan Attorneys Ranked in 2024 IAM Patent 1000

June 6, 2024

Intellectual Asset Management (IAM)

Press Release

Finnegan Receives Top Rankings from Intellectual Asset Management; 46 Attorneys Ranked Finnegan Receives Top Rankings from Intellectual Asset Management; 46 Attorneys Ranked

June 30, 2023

Intellectual Asset Management (IAM)

Press Release

45 Finnegan Attorneys Recommended by Intellectual Asset Management; Firm Continues to Be Top Ranked 45 Finnegan Attorneys Recommended by Intellectual Asset Management; Firm Continues to Be Top Ranked

July 8, 2022

Intellectual Asset Management (IAM)

Press Release

40 Finnegan Attorneys Ranked in IAM Patent 1000 40 Finnegan Attorneys Ranked in IAM Patent 1000

July 8, 2021

More

Professional Activities

  • American Intellectual Property Law Association
    (Editorial Board, AIPLA Quarterly Journal, 2013-2016)
  • American Bar Association
  • American Chemical Society
  • District of Columbia Bar Association
Admissions and Education

Admissions

  • U.S. Patent and Trademark Office
  • District of Columbia
  • Maryland

Education

Johns Hopkins University
M.S., Biotechnology, 2005
Franklin Pierce Law Center
J.D., 2002
University of North Carolina at Chapel Hill
B.S., Biology, 1995
University of North Carolina at Chapel Hill
B.A., Chemistry, 1995

Adriana's Practices

Global IP Enforcement, Litigation, and Trials
Patent Litigation and Trials
Pretrial Strategies
Prosecution and Portfolio Management
Appeals to the PTAB
Due Diligence
Ex Parte Reexamination (EPR)
IP Portfolio Management
Opinions and Counseling
Patent Drafting and Prosecution
Patent Reissues
Patent Term Extension (PTE) and Supplementary Protection Certificate (SPC)

Adriana's Industries

Chemicals, Industrials, and Materials
Chemical
Consumer Goods and Services
Consumer Products
Energy
Clean Energy and Renewables
Life Sciences
Biotechnology
Pharmaceutical

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP